| 注册
首页|期刊导航|中国药房|上海地区119家医院2008-2011年口服降糖药利用分析

上海地区119家医院2008-2011年口服降糖药利用分析

石卫峰 归成 李晓宇 黄堃 刘皋林

中国药房2013,Vol.24Issue(2):110-113,4.
中国药房2013,Vol.24Issue(2):110-113,4.DOI:10.6039/j.issn.1001-0408.2013.02.06

上海地区119家医院2008-2011年口服降糖药利用分析

Analysis of the Utilization of Oral Hypoglycemic Agents in 119 Hospitals of Shanghai Area during the Period of 2008-2011

石卫峰 1归成 1李晓宇 1黄堃 2刘皋林1

作者信息

  • 1. 上海交通大学附属第一人民医院药剂科,上海200080
  • 2. 上海市食品药品监督管理局科技情报所,上海200040
  • 折叠

摘要

Abstract

OBJECTIVE: To evaluate the status quo and tendency of the utilization of oral hypoglycemic agents(OHAs) in hospitals of Shanghai area. METHODS: By retrospective analysis, the utilization of OHAs in 119 hospitals of Shanghai area during the period of 2008 — 2011 was analyzed statistically in respect of categories of drugs, consumption sum, DDDs and DDC. RESULTS : The consumption sum of OHAs increased year by year in Shanghai area, with the growth rate slowing down. The top 4 OHAs in the list of consumption sum were acarbose, metformin, gliclazide and repaglinide, the sum of which accounting for 58.67% of the total in 4 years. In terms of DDDs, gliclazide, metformin, glipizide and acarbose ranked top 4. And glipizide, gliclazide and metformin had the lower DDC. CONCLUSION: The application of OHAs in Shanghai area is rational basically. The OHAs with high efficiency, good safety and tolerability are welcomed in the clinic.

关键词

口服降糖药/上海地区/销售金额/用药频度/日均费用/分析

Key words

Oral hypoglycemic agents/ Shanghai area/ Consumption sum/ DDDs/ DDC/ Analysis

分类

医药卫生

引用本文复制引用

石卫峰,归成,李晓宇,黄堃,刘皋林..上海地区119家医院2008-2011年口服降糖药利用分析[J].中国药房,2013,24(2):110-113,4.

中国药房

OACSCDCSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文